期刊文献+

肝移植术后肺部细菌感染的诊治 被引量:5

Diagnosis and treatment of bacterial pneumonia in the recipients of liver transplantation:a report of 33 cases
原文传递
导出
摘要 目的总结肝移植术后肺部细菌性感染的诊治经验。方法对33例同种异体原位肝移植后发生肺部细菌感染者的临床资料进行分析。结果33例术后住院期间发生肺部细菌感染53例次,所有患者的痰或胸水培养均有阳性发现;较常见的病原菌为铜绿色假单胞菌、肺炎克雷伯氏菌、鲍曼/溶血不动杆菌、金黄色葡萄球菌等;对革兰氏阴性杆菌敏感的抗生素有阿米卡星、亚胺培南、环丙沙星,对革兰氏阳性球菌敏感的抗生素有万古霉素;16例在感染治疗过程中发生急性排斥反应,死亡5例;治疗时根据药物敏感试验选用抗生素,必要时调整免疫抑制方案;33例中,治愈20例,死亡13例。结论肺部细菌感染是肝移植术后常见并发症,其诊断有赖于对临床资料综合分析,治疗上除应遵循一般肺部感染的处理原则外,应注意合理选择抗生素及对受者免疫功能的调控。 Objective To improve the diagnosis and treatment of bacterial pneumonia in the recipients of liver transplantation. Methods The data of the allogenic liver transplantations performed in our center were analyzed retrospectively. Results One hundred and three cases of allogenic liver transplantations were performed in our center from Feb. 1999 to Jan. 2003. Thirty three recipients had 53 episodes of bacterial pneumonia during their staying in the hospital after transplantation. Seven clinical manifestations and laboratory results were reviewed in these cases including expectoration, panting, fever, rates, white blood cell count, result of chest X ray and culture of tracheal secretions and pleural fluid. Only 42.4 % of the recipients with bacterial pneumonia were found to have more than 3 abnormal items in those 7 variables. The etiologies of bacterial pneumonia were pseudomonas aeruginosa ( 17.48 % ), Klebsiella pneumoniae ( 15.53 % ), Acinetobacter baumannii ( 10.68 % ), staphylococcus aureus ( 7.77 % ) and so on. The sensitive antibiotics included amilkacin, tienam, ciprofloxacin, vancomycin etc. Acute rejections occurred during the treatment of bacterial pneumonia in 16 cases, and 5 of those recipients died. Conclusion Bacterial pneumonia is a common complication after liver transplantation, and its diagnosis relies on overall analysis of the clinical information of the recipient. Attentions should be paid to reasonable use of antibiotics and mediation of immunity besides other routine therapies during the treatment of this complication.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2004年第5期288-290,共3页 Chinese Journal of Organ Transplantation
关键词 肺部细菌感染 术后 肝移植术 治疗 抗生素 诊断 临床资料 结论 培养 受者 Liver transplantation Pneumonia,bacterial
  • 相关文献

参考文献2

二级参考文献13

  • 1苑广盈.在肠杆菌科监测超广谱β-内酰胺酶的探讨[J].中华医学检验杂志,1998,21(4):238-238.
  • 2Weinstein RA. Nosocomial infection update[J]. Emerg Infect Dis, 1998, 4: 416-420.
  • 3Thomas MF Jr. Overview of resistance in 1990s[J]. Chest, 1999, 115: 3s-8s.
  • 4Thornsberry C, Ogilvie P, Kahn J, et al. Surveillance of an timicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States in 1996-1997 respiratory season[J]. Diagn Microb Infect Dis, 1997, 29: 249-257.
  • 5CDC. Update. Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997[J]. MMWR, 1997, 46: 813-815.
  • 6Murray BE. Vancomycin-resistant enterococci[J]. Am J Med, 1997, 102: 284-293.
  • 7Itokazu GS, Quinn JP, Bell-Dixon C, et al. Antimicrobial resistance rates among aerobic Gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program[J]. Clin Infect Dis, 1996, 23: 779-784.
  • 8Watanabe M, Lyobe S, Inoue M, et al. Transferableimipe-men resistance in Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 1991, 35: 147-151.
  • 9Suh B, Shapiro T, Jones R, et al. In vitro activity of β-lactamase inhibitors against clinical isolates of Acinetobacter species[J]. Diagn Microbiol Infect Dis, 1995, 21: 111-114.
  • 10Lecso-Bornet M, Bergogne-Berezi N. Susceptibility of 100 strains of Stenotrophomonas maltophilia to three β-lactams and five β-lactam β-lactamase inhibitor combinations[J]. J Antimicrob Chemother, 1997, 40: 717-720.

共引文献73

同被引文献21

  • 1Stardl TE, Fung J, Jordan M, et al.Kidney transplantation under FK506. J Am Med Assoc,1990,264(l):63-67.
  • 2Shaw LM, Kaplan B, Brayman, et al. Prospective investigations of concentration-clinic for immunosuppressive drugs provide the scientific basis for therapeutic drug monitoring. Clin Chem,1998, 44(2):381.
  • 3Plosker GL, Foster RH. Tacrolimus :a further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs, 2000,59:323-389.
  • 4Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis[J]. Clin Infect Dis,2000,30: 662- 678.
  • 5严律南 戴越盟 严律南 主编.肝移植概述[A].严律南,主编.肝脏外科[C].北京:人民卫生出版社,2002.741-743.
  • 6叶任高.内科学[M]5版.北京:人民卫生出版社,2001.258.
  • 7Singh N,Gayowski T, Wagener M, et al. Pulmonary infection in liver transplantion recipients receiving Tacrolimus [ J ].Transplantation, 1996,61 : 396-401.
  • 8Lee PH, Hu RH, Tsai MK, et al. Liver transplantion for patients with hepatitis B:prevention of hepatitis B recurrence by intravenous antihepatitis B immunoglobulin and lamivndine[ J ]. Transplant Proc ,2000,32:2245-2247.
  • 9Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis[J]. N Engl J Med,1996,334( 1 ):693- 699.
  • 10van-Thiel D H, Colantoni A,de-Maria N. Liver transplantation for hepatocellular carcinoma [ J ], Hepato Gastroenterol, 1998,45 (24) : 1944-1949

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部